Cel
Infections caused by antimicrobial-resistant bacteria (AMRB) account for an increasing proportion of healthcare-associated infections, particularly in high-risk units such as intensive care units and surgery; patients discharged to rehabilitation units often remain carriers of AMRB, contributing to their dissemination into longer-term care areas and within the community.
The overall objective of MOSAR is to gain breakthrough knowledge in the dynamics of transmission of AMRB, and address highly controversial issues by testing strategies to combat the emergence and spread of antimicrobial resistance, focusing on the major and emerging multi-drug antimicrobial resistant microorganisms in hospitals, now spreading into the community. Microbial genomics and human response to carriage of AMRB will be integrated with health sciences research, including interventional controlled studies in diverse hospital settings, mathematical modelling of resistance dynamics, and health economics.
Dziedzina nauki
- medical and health sciencesclinical medicinephysiotherapy
- medical and health scienceshealth sciences
- medical and health sciencesclinical medicinecritical care medicine
- social scienceseconomics and businesseconomicshealth economics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Zaproszenie do składania wniosków
FP6-2005-LIFESCIHEALTH-6
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
IP - Integrated ProjectKoordynator
PARIS
Francja
Zobacz na mapie
Uczestnicy (16)
85500 UTRECHT
Zobacz na mapie
TEL AVIV
Zobacz na mapie
LONDON
Zobacz na mapie
CRETEIL
Zobacz na mapie
105 LE CHESNAY
Zobacz na mapie
CHILLY MAZARIN
Zobacz na mapie
CARDIFF
Zobacz na mapie
HAMBURG
Zobacz na mapie
GENEVE 4
Zobacz na mapie